At the University Institute of Cancerology AP-HP Sorbonne University, teams from the pharmacology and internal medicine departments of the GHU AP-HP Sorbonne University, Inserm and Sorbonne University, coordinated by Prof. Joe-Elie Salem and Prof. Yves Allenbach, have developed a new treatment regimen to reduce mortality in patients suffering from cardiotoxicity due to certain immunotherapies widely used in the treatment of many cancers.
This study was published on February 23, 2023 in
Cancer Discovery
a journal of the American Association for Cancer Research (AACR).